Related Experiment Video
Updated: May 29, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Clinical considerations in the management of obesity in children and adolescents
Whitney Herring1, Carina Kugelmas2, Evan P Nadler3
1Mississippi Center for Advanced Medicine, 7730 Old Canton Road Building A, Madison, MS, 39110, USA.
Background:
Obesity is a complex, chronic disease affecting more than one-fifth of adolescent children aged 12-19 years in the United States. Recent guidelines have recommended optimization of diagnosis and treatment approaches to help improve the immediate and long-term health of people with obesity.
Methods:
Here, we describe the insights and recommendations of 9 nationally recognized experts in pediatric obesity, summarized from a virtual advisory board discussion.
Results:
Advisors described their background, experiences, and patient populations, conveyed the journey experienced by many pediatric patients with obesity, discussed the recent landscape for pharmacotherapy in adolescents, and provided their perspectives on updated American Academy of Pediatrics Clinical Practice Guidelines.
Conclusion:
Overall, the advisors agreed that the key to addressing the growing prevalence of obesity in children and adolescents depends on increased education in the medical field and community-wide initiatives to promote early intervention. Collaboration among all parties (e.g., physicians, policymakers, insurance companies, academic institutions, and researchers) to address barriers to treatment and reduce the social stigma surrounding obesity is also essential.
Related Concept Videos
Obesity
Binge Eating Disorders
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Anorexia Nervosa
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Bulimia Nervosa
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

